ATS View
한국어

Cosmax KRX:192820KOSPI

코스맥스 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h2
Articles, 7 days13
DART filings, 7 days1
Articles tracked13since Sep 11

In Q2 2026, Cosmax reported revenue of ₩795bn, up 27.5% year on year, and operating profit of ₩73.7bn. Cosmax (코스맥스) appeared in 13 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 11 with 10 articles. The most common catalyst was clinical & approvals (6).

Cosmax quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩795bn+27.5%₩73.7bn₩50.0bn
Q1 2026₩682bn+15.9%₩53.0bn₩43.8bn
Q4 2025 derived₩601bn+7.7%₩40.9bn₩87.9bn
Q3 2025₩586bn+10.5%₩42.7bn₩10.7bn
Q2 2025₩624bn+13.1%₩60.8bn₩21.8bn
Q1 2025₩589bn+11.7%₩51.3bn₩10.6bn
Q4 2024 derived₩558bn+27.8%₩39.8bn₩12.9bn
Q3 2024₩530bn+15.6%₩43.4bn₩20.6bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Cosmax top stories 2 weeks, by number of outlets

  1. 1
    코스맥스 "바쿠치올 활용한 주름개선 화장품, 식약처 허가 받아"
    3 outlets · 3 articlesFirst report Sep 11 10:19 한민족센터Regulatory approval
  2. 2
    코스맥스, '바쿠치올 고형제' 식약처 허가 획득...슬로우에이징 시장 선도
    2 outlets · 2 articlesFirst report Sep 11 08:41 더트래커Regulatory approval
  3. 3
    코스맥스, '바쿠치올 멀티밤' 개발…기능성 허가 획득
    1 outlets · 1 articlesFirst report Sep 11 09:18 청년일보Regulatory approval
  4. 4
    [카드] 코스맥스, 차세대 레티놀 '바쿠치올' 기능성 허가
    1 outlets · 1 articlesFirst report Sep 11 09:39 프라임경제
  5. 5
    코스맥스 "기능성 화장품 스틱 제형으로 구현"
    1 outlets · 1 articlesFirst report Sep 11 09:44 파이낸셜뉴스
  6. 6
    “원료부터 제형까지”... 코스맥스, 연구개발로 K뷰티 ‘기술 초격차’ 넓힌다
    1 outlets · 1 articlesFirst report Sep 11 15:28 시장경제신문

Latest Cosmax news Korean headlines